Trial intelligence / Profile preview

PREOB osteoblastic cell implantation in early-stage non-traumatic osteonecrosis of the femoral head

2009-012929-11Phase 3Terminated

Sponsor
BioSenic
Start
Jun 2011
Modality
Cell Therapies
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in osteonecrosis of the hip and osteonecrosis comparing Core decompression + PREOB implantation with Core decompression + placebo implantation (2 arms). Primary endpoint: Primary efficacy endpoints. Started Jun 2011; status: terminated.

02

Drugs

PREOB
03

Conditions

osteonecrosis of the hiposteonecrosis

Beyond the preview

Go deeper on 2009-012929-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012929-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call